Translational Science and Therapeutics Division, Fred Hutch
Director, Cord Blood Transplant Program
Dr. Filippo Milano is a physician-scientist whose research is focused on the use of umbilical cord blood as a source of stem cells for transplantation to treat blood cancers. He concentrates on clinical practice improvements with a goal of increasing the number of patients eligible for transplantation and to improve clinical outcomes for those who receive cord blood transplants. He has carried out pivotal analyses of blood cancer patients who have received transplants, comparing outcomes of cord blood recipients with those who had blood stem cell transplants from unrelated donors. Dr. Milano also studies the use of an experimental, off-the-shelf cord blood product designed to extend immunological protection to recipients of cord blood transplants until their donated cells are fully engrafted and proliferating.
Associate Professor, Division of Hematology and Oncology
University of Washington School of Medicine
Fellowship: Hematology, University La Sapienza and University of Washington
Residency: Internal Medicine, University La Sapienza
PhD, University La Sapienza
MD, University La Sapienza
Impact of Non HLA-matched off-the-shelf ex-vivo expanded cord blood progenitors on outcomes in patients undergoing cord blood transplantation
Use of Non HLA-matched off-the-shelf ex-vivo expanded cord blood progenitors for patients with HIV undergoing cord blood transplantation
Evaluation of the use of Treosulfan as part of the conditioning regimen in patients undergoing cord blood transplantation and haploidentical transplant
Use of TCR gene therapy to cure viral infections in patients undergoing cord blood transplantation
Use of a new molecule (UM171) to expand cord blood progenitors
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210